Biotechnology Industry Organization (BIO) Highlights Serious Flaws in Recommendations of Draft Report on Gene Patents and Patient Access to Genetic Tests

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) provided comments yesterday to the Secretary’s Advisory Committee on Genetics, Health and Society regarding its draft report on Gene Patenting and Licensing and Their Impact on Patient Access to Genetic Tests. The report makes several recommendations that would restrict the ability to obtain or undermine the enforceability of patents and exclusive licenses with respect to genetic tests.